|
|
Analysis of the BRCAI
gene alteration in Indian Pre- and post Menopausal
breast cancer patients. |
|
|
Clinical benefit
programme of Gemcite in patient with advanced non
small cell lung cancer (Multi Centric) (PT – II) |
|
|
A Multi-centric
phase-II study of Gemictabine, Paclitaxel and
cisplatin in chemotherapy naïve advance ovarian
cancer. |
|
|
An open label single
arm, multicentric study to assess the efficacy of
oral FACTIVE (semi floxacin) for the empirical
treatment in patients with respiratory tract
infection. |
|
|
Nosocomial infections
in OT multicentric trial |
|
|
Assessment of
Chemotherapy and radiation through study of cell
growth and decay. |
|
|
Pre-transfusion
status of patients with reference to hepatitis B and
AID virus. |
|
|
Phase III clinical
trials of radiotherapy and 2 DG in Glioblastoma
multiforme. |
|
|
Tolerability and efficacy
of capecitabine
as a radio sensitizer in squamous cell
carcinoma head and neck. |
|
|
Clinical trial of
high dose rate brachy therapy in Carcinoma
esophagus. |
|
|
Synchronous
Chemoradiation Therapy in cancer cervix, cancer head
and neck, cancer lung. |
|
|
Serum MDA and VITAMIN
E levels in patients of Carcinoma Cervix receiving
Radical Radiotherapy. |
|
|
Evaluation of
validity and feasibility of sentinal lymph node
biopsy in the management of node negative breast
cancer. |
|
|
Response of Docetaxel
(Taxotere) in Metastatic Ca Breast. |
|
|
Study of the response
of docetaxel (Taxotere) in Non small cell lung
cancer stage III B and stage IV as per TNM
classification. |
|
|
A Phase-II study of
Gemcitabine Plus Cistplatin in chemotherapy naive-
unresectable Gall Bladder Cancer (Multi centric),
code No. B-9E IN 0095. |
|
|
A pilot study of
Irinotecan (Campto) (Cpt-11) in advance non-small
cell lung cancer. |
|
|
Pilot Study –
metastatic CA Lung; Role of Texotere in metastatic
CA Lung; Role of Texotere in metastatic CA Breast. |
|
|
Role of interstitial
Brachytherapy in Brain Cancer. |
|
|
Study of the response
of Docetaxel (Taxotere) in Non small cell lung
cancer stage III B and stage IV as per TNM
classification. |
|
|
Molecular research
project on expression on P53 and NFKB tumor marker
in head and neck cancer. |
|
|
Hospital Tumour
Registry: Statistical data collection of various
types of cancer detected in the hospital. |
|
|
Concomitant
temozolamide and radiotherapy in Glioblastoma
Multiforme (GBM). |
|
|
Concomitant
administration of paclitaxel and radiotherapyin head
and neck cancer. |
|
|
Testing of micro
satellite instability on chromosome 16 in Breast
cancer. |
|
|
Epidemiological study
on role of cancer screening in early detection of
cancers. |
|
|
Role of new adjuvant
chemotherapy followed by radical radiotherapy in
advanced head and neck cancer. |
|
|
Role of interferon L2
with combination chemotherapy (hydroxyurea and
cytosine arbinoside) in the management of chronic
myeloid leukemia. |
|
|
GM-CSF in the
prevention of severe neutropenia in the patients
receiving intensive chemotherapy. |
|
|
Extended field
radiotherapy for carcinoma cervix.
|
|
|
Role of granulocyte
microphage colony stimulating factor in chemotherapy
induced neutropenia. |
|
|
Role of paclitaxel
plus carboplatin as second line treatment in
relapsed carcinoma ovary. |
|
|
Evaluation of the use
of amifostine (Ethyol) as a protector normal tissue
during cytotoxic chemotherapy for advanced head and
neck cancers. |
|
|
Evaluation of
hematopoietic growth factors as adjuvant therapy in
the treatment of acute leukemia. |
|
|
Evaluation o
interferon alpha with combination chemotherapy in
the neoadjuvant setting for head and neck cancers. |
|
|
Analysis of Genetic
Polymorpheris of P73 and P53 and the risk of cancers
in Indian patients |
|
|
Molecular Analysis of
FHIT Gene and P16 and their association with HPV in
Indian Head and Neck Carcinoma patients |
|
|
Pain scores post
operatively after giving NSAID + Opiods + Homeopathy
pre operatively and post operatively and accessing
its results |
|
|
Prophylactic use of
amifostine to prevent concomitant chemotherapy,
radiotherapy induced mucositis and xerostomia in
Head and Neck Cancer |
|
|
Cytological grading
of Ca Breast on FNAC and its correlation with
histological grading. |
|
|
Molecular markers in
Ca Breast in collaboration with JNU. |
